The addition of norepinephrine to cultured glioblastoma cells results in an inhibition of uptake of radioactivity from D-[2_3H]glucose, D_[1_14C]glucose, D42-14C]glucose, and D- [6-14C]glucose. In addition, if the glioblastoma cells are previously labeled with these substrates, norepinephrine causes an increase in the release of radioactivity. These effects were not observed with cultured neuroblastoma cells. It is suggested that the breakdown of glycogen is activated by norepinephrine as a result of an increase in 3': 5'-cyclic AMP.
Several years ago Galambos (1) postulated that, in addition to neuron-neuron synapses, neuron-glia synapses occur. A metabolic relationship existing between neurons and glia was suggested originally by Hyden and Lange (2) on the basis of whole animal studies and more recently by Gilman and Nirenberg (3) on the basis of the finding that the neurotransmitter, norepinephrine, causes an increase in 3': 5'-cyclic AMP (cAMP) in rat glioblastoma cells in cell culture. These findings were substantiated by Clark and Perkins (4) , who also found a rapid increase in the concentration of cAMP of epinephrine and histamine, in addition to norepinephrine, in a tumor astrocyte cell-line derived from a primary culture of a human glioblastoma multiforme. It is known from the early work of Rall and Sutherland (5) that glycogenolysis was increased by cAMP due to activation of a protein kinase that converts phosphorylase b to phosphorylase a, the active form of the enzyme.
On the basis of these several results, it seemed of interest to examine in cell culture the effect of norepinephrine on glucose incorporation and excretion in glioblastoma and neuroblastoma cells.
MATERIALS AND METHODS Cell line and culture
Clone C-6, derived from a rat (Wistar strain) astrocytoma induced by N-nitrosomethylurea, and clone C-46, derived from a mouse neuroblastoma, were obtained from Dr. G. Sato (6) . Clones C-6 and C-46 were grown in Dulbecco's modified Eagle's (7) medium with 10% fetal-calf serum in Falcon flasks or petri dishes at 370 in an atmosphere of 10% C02-90% air at 100% humidity.
Radioactivity experiments
For the radioactivity experiments, 60-mm petri dishes were incubated with about 3 X 106 cells for 2 days in the above medium. By this time the cells were confluent. The medium was then changed to 2 ml of fresh modified Eagle's medium or Earle's (8) 
RESULTS
Since the total cells in each dish were collected on Millipore filters for the determination of radioactivity, it was not possible to count the number of cells present nor to do a protein determination to account for any variability due to differences in cell numbers. To account for the latter, it was necessary to use two substrates in each experiment, one labeled with 8H and the other with 14C. In each experiment, The cells were incubated for 2 days in Dulbecco's modified Eagle's medium plus 10% fetal-calf serum. Each 60-mm petri dish was initially inocculated with 3. X 106 cells in 3 ml of medium. The growth medium was removed and replaced with 2 ml of Earle's balanced salt solution containing the radioactive substrates. The cells were then incubated for an additional 30 min before they were filtered through a Millipore filter. When the cells were previously incubated in the presence of theophylline, growth medium was replaced with new growth medium containing 1 mM of theophylline, and the cells were incubated for 1 hr. This latter medium was then removed, replaced with Table  1 ). When the cells are not previously incubated in theophylline, there is an inhibition by norepinephrine of from 20-50%
in the incorporation of glucose. Less inhibition (10-30%) was found when the cells are previously incubated in theophylline.
If the cells are incubated as previously described, except that modified Eagle's medium plus 10% fetal-calf serum is used in place of balanced salt solution, similar results are obtained (Table 2 ). In another series of experiments, the cells were incubated for 2 hr in the presence of radioactive substrates and washed; the medium was then changed to balanced salt solution. The cells were incubated for 30 min in the presence of 1 mM of theophylline and norepinephrine. As shown in Table 3 , norepinephrine caused an increase in the release of isotope from the cells, as evidenced by the presence of less radioactivity in these cells.
In another series of experiments, the evolution of 14CO2 from specifically labeled ['4C]glucose was determined. As shown in Table 4 , the addition 6f norepinephrine caused an Table 5 , norepinephrine had no effect on the incorporation of label from radioactive glucose in these cells.
DISCUSSION
In these experiments we examined the question of whether norepinephrine affects the uptake of radioactive glucose, the release of radioactive compounds derived from radioactively labeled glucose, or the metabolism of radioactive glucose in glioblastoma and neuroblastoma cells in culture. From the results presented it appears that the addition of norepinephrine affects these processes in glioblastoma cells and not in neuroblastoma cells in cell culture.
We suggest that the process occurring in glioblastoma cells can be explained as shown in Fig. 2 . The breakdown of glycogen is activated by norepinephrine as a result of an increase in cAMP (2, 3), which activates the protein kinase for conversion of phosphorylase b to phosphorylase a. This process results in an increase of glucose within the cell. If radioactive glucose is added to the medium less will be taken into the cell because of an increase in an intracellular pool of glucose or compounds derived from glucose. This is the result that was obtained (Tables 1 and 2) . If the cells are previously labeled with glucose and the medium containing the radioactive compounds is removed, then it might be expected that radioactivity would be lost from the cell in the presence of norepinephrine. This occurred (Table 3 ). In addition, it might be expected that if norepinephrine caused an increased conversion of glycogen to glucose, increased oxidation of the glucose would also occur. The results shown in Table 4 are consistent with this postulate.
Although we may speculate that the effect of norepinephrine is on the breakdown of glycogen, the nature of the experiments do not permit an unequivocal conclusion in this regard. This would require determination of the products derived from the radioactive glucose and the nature of the compounds lost from the cell in the presence of norepinephrine. Nevertheless, we propose that in vivo these products from glia cells are made available to neurons and used for metabolic processes in the neurons, assuming the present experiments might have relevance to the intact brain. Thus, one can envision the relation of neurons and glia cells to be one whereby a neurotransmitter from neurons triggers a reaction in glia cells that results in the latter providing metabolites to the neuron for various synthetic reactions or generating energy for cellular processes.
